<DOC>
	<DOCNO>NCT01838031</DOCNO>
	<brief_summary>Estimate proper thyroid screen method pregnancy . Evaluate maternal subclinical hypothyroidism treatment pregnancy result improved pregnancy outcome cognitive function child .</brief_summary>
	<brief_title>Thyroid Screening Protocol During Pregnancy : Multi-center Prospective Controlled Study</brief_title>
	<detailed_description>The investigator conduct single-blinded trial pregnant woman gestation le 12 week , usually 6 8 week , provide blood sample measurement thyrotropin , free thyroxine ( FT4 ) thyroid peroxidase antibody ( TPOAb ) . Women assign screen group PUMCH ( measurement obtain immediately ) control group HMCHH ( serum store measurement obtain shortly delivery ) . Each group enrol 1000 pregnant woman separately . Women positive finding screen group give individualized levothyroxine treatment regular follow-up . Compare pregnancy outcomes , IQ 2-3 year age child woman subclinical hypothyroidism two group .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>All pregnant woman receive prenatal care PUMCH HMCHH Sign consent form agree followup pregnancy outcome child pregnant woman agree enter study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>antenatal thyroid screening</keyword>
	<keyword>subclinical hypothyroidism</keyword>
	<keyword>thyroid function</keyword>
	<keyword>thyroid antibody</keyword>
	<keyword>pregnancy outcome</keyword>
	<keyword>childhood cognitive function</keyword>
</DOC>